Application 215331

Type
NDA
Sponsor
MAIA PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BORTEZOMIBBORTEZOMIBINJECTABLE;INTRAVENOUS, SUBCUTANEOUS3.5MG/3.5ML/VIALNoNo
002BORTEZOMIBBORTEZOMIBINJECTABLE;INTRAVENOUS, SUBCUTANEOUS3.5MG/1.4ML/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70511-161BortezomibbortezomibMAIA Pharmaceuticals, Inc.NDACurrent
70511-162BortezomibbortezomibMAIA Pharmaceuticals, Inc.NDACurrent
72266-243BortezomibbortezomibFOSUN PHARMA USA INCNDACurrent
72266-244BortezomibbortezomibFOSUN PHARMA USA INCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74617ORIG 2023-06-23
71660ORIG2022-07-28
71655ORIG2022-07-28